Medical testing done by the closely watched start-up Theranos was plagued by quality control problems that could have led to inaccurate results for patients, according to an inspection report released by federal regulators on Thursday.
Among other findings in the report, which ran 121 pages, the company used unqualified or inadequately trained personnel and stored samples in freezers that were not at the proper temperature. It also failed to ensure that the quality control for an important blood-clotting test was acceptable before reporting results for patients.
Read Full Article »